Matthew Might

Matthew Might champions interdisciplinary research on rare disease discovery and diagnosis, personalized therapeutics, and precision prevention. Since joining the faculty of the Department of Biomedical Informatics at Harvard Medical School in 2015, he has been at the forefront of integrating computer and data science into clinical and academic medicine. His work is pivotal in advancing the understanding and treatment of rare diseases, as well as in developing innovative approaches for cancer and common chronic conditions. At Harvard, Matthew's research is driven by a commitment to improving patient outcomes through personalized medicine. By leveraging cutting-edge bioinformatics tools, he seeks to tailor therapeutic interventions to individual patient profiles, thereby maximizing efficacy and minimizing adverse effects. His efforts in precision prevention aim to preemptively address health issues before they manifest, particularly in the context of rare diseases and cancer. Matthew's contributions extend beyond the laboratory, as he actively collaborates with clinicians, researchers, and policymakers to translate his findings into practical applications. His work not only enhances the capabilities of healthcare professionals but also empowers patients with rare and complex conditions by providing them with more accurate diagnoses and effective treatment options. In addition to his research, Matthew is dedicated to mentoring the next generation of scientists and healthcare professionals. Through his teaching and guidance, he inspires students to pursue innovative solutions to some of the most pressing challenges in medicine today. His passion for interdisciplinary collaboration and his commitment to advancing the field of biomedical informatics make him a respected leader and visionary in his field.